|
Feb 1, 2013
By:
Stan Bernard, MD
"Drug Life Optimization" can wrest more value through strategies that build a drug's brand franchise through its entire lifespan, according to Stan Bernard.
|
|
Sep 1, 2012
By:
Stan Bernard, MD
"Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets."
|
Aug 1, 2012
By:
Stan Bernard, MD
Creative non-pharmaceutical partnerships can offer innovators unique capabilities against the competition in a new era where challenges to market leadership are coming from every direction.
|
|
Oct 1, 2011
By:
Stan Bernard, MD
The product launch has been transformed from a concentrated, all-out military assault to the subtle, persuasive art of electioneering.
|
May 1, 2011
By:
Stan Bernard, MD
Innovator and generics companies are colliding as they invade each other's turf
|
Apr 1, 2011
By:
Stan Bernard, MD
It can take both a clinical and non-clinical approach to win the differentiation competition
|
With the impact of the sales rep on revenue flows in decline, it's time to beef up training
Feb 1, 2011
By:
Stan Bernard, MD
With the impact of the sales rep in decline, it's time to beef up training for other pharma functions to fill the gap in a competitive marketplace
|
A clear, consistent approach to the competition can deliver big gains in market share; six decisions lead the way
Oct 1, 2010
By:
Stan Bernard, MD
A clear, consistent approach to the competition can deliver big gains in market share; six decisions lead the way
|
Jul 1, 2010
By:
Stan Bernard, MD
Teva Pharmaceuticals has emerged as the industry's most formidable foe.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
